CDF 2022 Year in Review
We are pleased to share this overview of our work in 2022, and we thank our individual donors and corporate partners for their ongoing generosity that makes this work possible.
Continue ReadingWe are pleased to share this overview of our work in 2022, and we thank our individual donors and corporate partners for their ongoing generosity that makes this work possible.
Continue ReadingCeliac Disease Foundation honors retiring Board Member Jim Watson for his dedicated service.
Continue ReadingCeliac Disease Foundation honors retiring Board Member Rhonda Resnick for her dedicated service.
Continue ReadingWith more than 200 symptoms, celiac disease can be difficult to diagnose. If you have unexplained symptoms or have a family member with celiac disease, complete the Symptoms Assessment Tool made possible by the generous support of Proud Sponsor Schär.
Continue ReadingA new study has found that celiac disease (CeD) is linked to a higher risk of Juvenile Idiopathic Arthritis (JIA) among children with CeD and Rheumatoid Arthritis (RA) in adults with CeD.
Continue ReadingAs Thanksgiving approaches, we at the Celiac Disease Foundation are grateful for you, our celiac community, and the progress we are making – together – to accelerate diagnosis, treatment, and a cure for celiac disease.
Continue ReadingMedical Advisory Board Member Alessio Fasano, MD, and CDF Research Grant Award Recipient Marisa Stahl, MD, are among the leading celiac disease doctors and researchers who are recommending that celiac disease patients be tested for other autoimmune disorders.
Continue ReadingEvery November, the Celiac Disease Foundation hosts our annual, beloved Turkey Trot 5K, an inspirational event that raises funds for celiac disease research to accelerate treatments and a cure.
Continue ReadingA new report released by an international group of researchers finds that pediatric celiac disease varies by region, and recommends a “low threshold for screening and further research on region-specific celiac disease triggers.”
Continue ReadingThe Celiac Disease Foundation is pleased to announce it will provide patient recruitment and eligibility screening for Anokion’s phase 1b/2 clinical trial for KAN-101.
Continue Reading